AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 35 filers reported holding AQUINOX PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $188,000 | +11.2% | 13,216 | +9.9% | 0.00% | 0.0% |
Q2 2017 | $169,000 | -19.1% | 12,024 | -3.8% | 0.00% | 0.0% |
Q1 2017 | $209,000 | -18.0% | 12,502 | -19.2% | 0.00% | -33.3% |
Q4 2016 | $255,000 | +75.9% | 15,474 | +42.5% | 0.00% | +50.0% |
Q3 2016 | $145,000 | +70.6% | 10,858 | -15.3% | 0.00% | +100.0% |
Q2 2016 | $85,000 | -24.1% | 12,814 | +1.3% | 0.00% | -50.0% |
Q1 2016 | $112,000 | -35.3% | 12,646 | -8.6% | 0.00% | 0.0% |
Q4 2015 | $173,000 | – | 13,843 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 877,753 | $14,492,000 | 5.61% |
RA Capital Management | 2,191,977 | $36,190,000 | 5.13% |
Opaleye Management Inc. | 310,000 | $5,118,000 | 3.02% |
EMORY UNIVERSITY | 143,691 | $2,372,000 | 2.34% |
Baker Brothers Advisors | 10,536,092 | $173,951,000 | 1.70% |
Ghost Tree Capital, LLC | 225,000 | $3,715,000 | 0.89% |
Cormorant Asset Management, LP | 151,838 | $2,507,000 | 0.34% |
Eventide Asset Management | 175,000 | $2,889,000 | 0.19% |
JGP Global Gestao de Recursos Ltda. | 11,380 | $188,000 | 0.10% |
Virtus ETF Advisers LLC | 16,347 | $270,000 | 0.08% |